Back

Prognostic stratification of end stage hypertrophic cardiomyopathy using cardiac magnetic resonance based late gadolinium enhancement granularity

11 December 2025 (15:30 - 16:15)
Organised by: Logo
Congress Presentation Part of: The key role of cardiovascular magnetic resonance in heart failure Late Gadolinium Enhancement EACVI Premium Access EACVI 2025 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Doctor Julien Hudelo

Hospital Lariboisiere, Paris (France)

6 More presentations in this session

Presentation thumbnail
Extracting tissue pathology from native oxygenation-sensitive CMR images using artificial intelligence
Doctor M. Benovoy (CA)
Abstract Slides
Presentation thumbnail
Incremental prognostic value of LGE granularity risk score in non-ischaemic dilated cardiomyopathy
Doctor T. Goncalves (Toronto, CA)
Abstract Slides
Presentation thumbnail
Cardiac magnetic resonance imaging for the diagnosis of cardiac amyloidosis in patients with heart failure
Miss L. Unger (Leipzig, DE)
Abstract Slides
Presentation thumbnail
Optimal cut off point of LVEF value using cardiovascular magnetic resonance for prognostic stratification in end stage hypertrophic cardiomyopathy
Doctor J. Hudelo (Paris, FR)
Abstract Slides
Presentation thumbnail
Additional predictive role of cardiac magnetic resonance feature-tracking right ventricular global longitudinal strain in patients with reduced ejection fraction: results from the DERIVATE registry
Doctor M. Ciarlantini (Bologna, IT)
Abstract Slides

Access the full session

Session thumbnail
The key role of cardiovascular magnetic resonance in heart failure

The Event

Event poster

EACVI 2025

11 December 2025 15:30 CET
You may be interested in
thumbnail
Congress Presentation
Late enhancement, lasting impact: left ventricular fibrosis in arrhythmogenic right ventricular cardiomyopathy
thumbnail
Congress Presentation
Prognostic impact of non-ischaemic late gadolinium enhancement in patients with ischaemic cardiomyopathy
thumbnail
Congress Presentation
Cardiovascular magnetic resonance late gadolinium enhancement risk score for mortality in hypertrophic cardiomyopathy: the HCM-LGE risk score

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources